Absolute quantification of multidrug resistance-associated protein 2 (MRP2/ABCC2) using liquid chromatography tandem mass spectrometry

Analytical Biochemistry

Volumn 380, Issue 2, 2008, Pages 211-222

  Li, Na ^a   Nemirovskiy, Olga V ^a   Zhang, Yiqun ^a   Yuan, Haodan ^a   Mo, Jianming ^a   Ji, Chengjie ^b   Zhang, Bo ^a   Brayman, Timothy G ^a   Lepsy, Christopher ^b   Heath, Timothy G ^a   Lai, Yurong ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b PFIZER INC   (United States)

Author keywords

ABC transporters; Absolute quantification; LC MS MS; MRP2 ABCC2

Indexed keywords

MASS SPECTROMETRY; METABOLITES; PEPTIDES;

ABC TRANSPORTER; ABSOLUTE QUANTIFICATION; COEFFICIENT OF VARIATION; LC-MS/MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LOWER LIMIT OF QUANTIFICATIONS; MRP2/ABCC2; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;

LIQUID CHROMATOGRAPHY;

ABC TRANSPORTER; AMINO ACID; COMPLEMENTARY DNA; GLUTAMINE; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MULTIDRUG RESISTANCE PROTEIN 2; PENICILLIN DERIVATIVE; STREPTOMYCIN; SYNTHETIC PEPTIDE; TRYPSIN;

ANIMAL CELL; ARTICLE; CELL STRAIN; DOG; DRUG METABOLISM; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETER; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; RAT; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY;

EID: 47749096296     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2008.05.032     Document Type: Article

References (31)

1. Mizuno N., Niwa T., Yotsumoto Y., and Sugiyama Y. Impact of drug transporter studies on drug discovery and development. Pharmacol. Rev. 55 (2003) 425-461
2. Arias I.M., Che M., Gatmaitan Z., Leveille C., Nishida T., and St Pierre M. The biology of the bile canaliculus 1993. Hepatology 17 (1993) 318-329
3. Alrefai W.A., and Gill R.K. Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm. Res. 24 (2007) 1803-1823
4. Kostrubsky V.E., Vore M., Kindt E., Burliegh J., Rogers K., Peter G., Altrogge D., and Sinz M.W. The effect of troglitazone biliary excretion on metabolite distribution and cholestasis in transporter-deficient rats. Drug Metab. Dispos. 29 (2001) 1561-1566
5. Stieger B., Fattinger K., Madon J., Kullak-Ublick G.A., and Meier P.J. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 118 (2000) 422-430
6. Kostrubsky V.E., Strom S.C., Hanson J., Urda E., Rose K., Burliegh J., Zocharski P., Cai H., Sinclair J.F., and Sahi J. Evaluation of hepatotoxic potential of drugs by inhibition of bile-acid transport in cultured primary human hepatocytes and intact rats. Toxicol. Sci. 76 (2003) 220-228
7. Ishizuka H., Konno K., Shiina T., Naganuma H., Nishimura K., Ito K., Suzuki H., and Sugiyama Y. Species differences in the transport activity for organic anions across the bile canalicular membrane. J. Pharmacol. Exp. Ther. 290 (1999) 1324-1330
8. Shilling A.D., Azam F., Kao J., and Leung L. Use of canalicular membrane vesicles (CMVs) from rats, dogs, monkeys and humans to assess drug transport across the canalicular membrane. J. Pharmacol. Toxicol. Methods 53 (2006) 186-197
9. Ninomiya M., Ito K., and Horie T. Functional analysis of dog multidrug resistance-associated protein 2 (Mrp2) in comparison with rat Mrp2. Drug Metab. Dispos. 33 (2005) 225-232
10. Ninomiya M., Ito K., Hiramatsu R., and Horie T. Functional analysis of mouse and monkey multidrug resistance-associated protein 2 (Mrp2). Drug Metab. Dispos. 34 (2006) 2056-2063
11. Barr J.R., Maggio V.L., Patterson Jr. D.G., Cooper G.R., Henderson L.O., Turner W.E., Smith S.J., Hannon W.H., Needham L.L., and Sampson E.J. Isotope dilution--mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. Clin. Chem. 42 (1996) 1676-1682
12. Wu S.L., Amato H., Biringer R., Choudhary G., Shieh P., and Hancock W.S. Targeted proteomics of low-level proteins in human plasma by LC/MSn: using human growth hormone as a model system. J. Proteome Res. 1 (2002) 459-465
13. Barnidge D.R., Goodmanson M.K., Klee G.G., and Muddiman D.C. Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-Ms/MS using protein cleavage and isotope dilution mass spectrometry. J. Proteome Res. 3 (2004) 644-652
14. Kuhn E., Wu J., Karl J., Liao H., Zolg W., and Guild B. Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics 4 (2004) 1175-1186
15. Lu Y., Bottari P., Turecek F., Aebersold R., and Gelb M.H. Absolute quantification of specific proteins in complex mixtures using visible isotope-coded affinity tags. Anal. Chem. 76 (2004) 4104-4111
16. Nemirovskiy O.V., Dufield D.R., Sunyer T., Aggarwal P., Welsch D.J., and Mathews W.R. Discovery and development of a type II collagen neoepitope (TIINE) biomarker for matrix metalloproteinase activity: from in vitro to in vivo. Anal. Biochem. 361 (2007) 93-101
17. Barnidge D.R., Dratz E.A., Martin T., Bonilla L.E., Moran L.B., and Lindall A. Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. Anal. Chem. 75 (2003) 445-451
18. Gerber S.A., Rush J., Stemman O., Kirschner M.W., and Gygi S.P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. USA 100 (2003) 6940-6945
19. John H., Walden M., Schafer S., Genz S., and Forssmann W.G. Analytical procedures for quantification of peptides in pharmaceutical research by liquid chromatography-mass spectrometry. Anal. Bioanal. Chem. 378 (2004) 883-897
20. Anderson N.L., and Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1 (2002) 845-867
21. Mallick P., Schirle M., Chen S.S., Flory M.R., Lee H., Martin D., Ranish J., Raught B., Schmitt R., Werner T., Kuster B., and Aebersold R. Computational prediction of proteotypic peptides for quantitative proteomics. Nat. Biotechnol. 25 (2007) 125-131
22. Choudhuri S., and Klaassen C.D. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int. J. Toxicol. 25 (2006) 231-259
23. Jedlitschky G., Hoffmann U., and Kroemer H.K. Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition. Expert Opin. Drug Metab. Toxicol. 2 (2006) 351-366
24. Kostiainen R., Kotiaho T., Kuuranne T., and Auriola S. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies. J. Mass Spectrom. 38 (2003) 357-372
25. Anderson L., and Hunter C.L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 5 (2006) 573-588
26. Mayya V., Rezual K., Wu L., Fong M.B., and Han D.K. Absolute quantification of multisite phosphorylation by selective reaction monitoring mass spectrometry: determination of inhibitory phosphorylation status of cyclin-dependent kinases. Mol. Cell Proteomics 5 (2006) 1146-1157
27. Barnidge D.R., Hall G.D., Stocker J.L., and Muddiman D.C. Evaluation of a cleavable stable isotope labeled synthetic peptide for absolute protein quantification using LC-MS/MS. J. Proteome Res. 3 (2004) 658-661
28. Yang Z., Hayes M., Fang X., Daley M.P., Ettenberg S., and Tse F.L. LC-MS/MS approach for quantification of therapeutic proteins in plasma using a protein internal standard and 2D-solid-phase extraction cleanup. Anal. Chem. 79 (2007) 9294-9301
29. Li W.W., Nemirovskiy O., Fountain S., Rodney Mathews W., and Szekely-Klepser G. Clinical validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide: a biomarker of matrix metalloproteinase activity and osteoarthritis in human urine. Anal. Biochem. 369 (2007) 41-53
30. Berna M.J., Zhen Y., Watson D.E., Hale J.E., and Ackermann B.L. Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis. Anal. Chem. 79 (2007) 4199-4205
31. Pratt J.M., Simpson D.M., Doherty M.K., Rivers J., Gaskell S.J., and Beynon R.J. Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by QconCAT genes. Nat. Protoc. 1 (2006) 1029-1043